An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...
A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
From life-saving medicine to gratitude for caregivers and a surprise romance, these stories remind us of the power of human connection.
Research at MSK Our research impact Research topics Core facilities & resources ...
We apply both precision gene editing and large-scale CRISPR screening in human pluripotent stem cells (hPSCs) to explore mechanisms underlying human development. Specifically, we are interrogating the ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Saturday, March 15, 2025 - 1:00 p.m. to 2:00 p.m.
Wednesday, March 19, 2025 - 1:00 p.m. to 2:00 p.m.
Wednesday, February 26, 2025 - 1:00 p.m. to 2:00 p.m.
Wednesday, December 18, 2024 - 1:00 p.m. to 2:00 p.m.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback